Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4099047
Max Phase: Preclinical
Molecular Formula: C32H51NO9
Molecular Weight: 593.76
Molecule Type: Small molecule
Associated Items:
ID: ALA4099047
Max Phase: Preclinical
Molecular Formula: C32H51NO9
Molecular Weight: 593.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO[C@@H]1[C@@H](O)[C@H](OC)[C@@H](C)O[C@H]1N(OC)[C@@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C4=CC(=O)OC4)CC[C@]32O)C1
Standard InChI: InChI=1S/C32H51NO9/c1-17-27(38-4)26(36)28(39-5)29(42-17)33(40-6)20-9-11-30(2)19(14-20)7-8-22-23(30)15-24(34)31(3)21(10-12-32(22,31)37)18-13-25(35)41-16-18/h13,17,19-24,26-29,34,36-37H,7-12,14-16H2,1-6H3/t17-,19-,20-,21-,22-,23+,24-,26+,27-,28-,29-,30+,31+,32+/m1/s1
Standard InChI Key: TZHIQTHPCJEWOT-HEXWDTNDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 593.76 | Molecular Weight (Monoisotopic): 593.3564 | AlogP: 2.58 | #Rotatable Bonds: 6 |
Polar Surface Area: 127.15 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.85 | CX Basic pKa: | CX LogP: 2.08 | CX LogD: 2.08 |
Aromatic Rings: 0 | Heavy Atoms: 42 | QED Weighted: 0.31 | Np Likeness Score: 2.45 |
1. Wang DD, Li XS, Bao YZ, Liu J, Zhang XK, Yao XS, Sun XL, Tang JS.. (2017) Synthesis of MeON-neoglycosides of digoxigenin with 6-deoxy- and 2,6-dideoxy-d-glucose derivatives and their anticancer activity., 27 (15): [PMID:28633895] [10.1016/j.bmcl.2017.06.008] |
Source(1):